PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18519799-14	2008	The use of dichloroacetic acid or leelamine, two PDK inhibitors, or a specific PDK4 siRNA demonstrated that PDK4 participated in glyceroneogenesis, therefore altering nonesterified fatty acid release in both basal and rosiglitazone-activated conditions.	Dichloroacetic Acid	11-30	pyruvate dehydrogenase kinase 4	Rattus norvegicus	108-112	
27413020-12	2016	Finally, the preventive effect of GW0742 on oxidative stress and cAMP-induced relaxation were overcome by the pyruvate dehydrogenase kinase 4 (PDK4) inhibitor dichloroacetate (DCA).	Dichloroacetic Acid	159-174	pyruvate dehydrogenase kinase 4	Rattus norvegicus	110-141	
27413020-12	2016	Finally, the preventive effect of GW0742 on oxidative stress and cAMP-induced relaxation were overcome by the pyruvate dehydrogenase kinase 4 (PDK4) inhibitor dichloroacetate (DCA).	Dichloroacetic Acid	159-174	pyruvate dehydrogenase kinase 4	Rattus norvegicus	143-147	
27413020-12	2016	Finally, the preventive effect of GW0742 on oxidative stress and cAMP-induced relaxation were overcome by the pyruvate dehydrogenase kinase 4 (PDK4) inhibitor dichloroacetate (DCA).	Dichloroacetic Acid	176-179	pyruvate dehydrogenase kinase 4	Rattus norvegicus	110-141	
27413020-12	2016	Finally, the preventive effect of GW0742 on oxidative stress and cAMP-induced relaxation were overcome by the pyruvate dehydrogenase kinase 4 (PDK4) inhibitor dichloroacetate (DCA).	Dichloroacetic Acid	176-179	pyruvate dehydrogenase kinase 4	Rattus norvegicus	143-147	
23045346-6	2012	Simvastatin with DCA maintained body mass gain and food intake, abrogated the myopathy, decreased muscle PDK4 mRNA and protein, MAFbx and cathepsin-L mRNA, increased activity of PDC and reduced proteasome activity compared with simvastatin.	Dichloroacetic Acid	17-20	pyruvate dehydrogenase kinase 4	Rattus norvegicus	105-109	
24527778-8	2014	In turn, the effects induced by the agonists were suppressed when HUVEC were also incubated with the PPARbeta antagonist GSK0660, the pyruvate dehydrogenase kinase (PDK)4 inhibitor dichloroacetate or after knockdown of both PPARbeta and PDK4 with siRNA.	Dichloroacetic Acid	181-196	pyruvate dehydrogenase kinase 4	Rattus norvegicus	165-170	
24527778-8	2014	In turn, the effects induced by the agonists were suppressed when HUVEC were also incubated with the PPARbeta antagonist GSK0660, the pyruvate dehydrogenase kinase (PDK)4 inhibitor dichloroacetate or after knockdown of both PPARbeta and PDK4 with siRNA.	Dichloroacetic Acid	181-196	pyruvate dehydrogenase kinase 4	Rattus norvegicus	237-241	
32347035-6	2021	Intraperitoneal injection of DCA of 50 mg/ kg body weight was used for the inhibition of Pyruvate Dehydrogenase Kinase 4 (PDK4) in the myocardium.	Dichloroacetic Acid	29-32	pyruvate dehydrogenase kinase 4	Rattus norvegicus	89-120	
32347035-6	2021	Intraperitoneal injection of DCA of 50 mg/ kg body weight was used for the inhibition of Pyruvate Dehydrogenase Kinase 4 (PDK4) in the myocardium.	Dichloroacetic Acid	29-32	pyruvate dehydrogenase kinase 4	Rattus norvegicus	122-126	
32347035-9	2021	Results: The results of the study showed that PDK4 gene expression in the endurance training group, diabetes+endurance training group, diabetes+endurance training+DCA group and endurance training+DCA group was higher compared to the control group.	Dichloroacetic Acid	163-166	pyruvate dehydrogenase kinase 4	Rattus norvegicus	46-50	
32347035-9	2021	Results: The results of the study showed that PDK4 gene expression in the endurance training group, diabetes+endurance training group, diabetes+endurance training+DCA group and endurance training+DCA group was higher compared to the control group.	Dichloroacetic Acid	196-199	pyruvate dehydrogenase kinase 4	Rattus norvegicus	46-50